Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 21, 2016; 22(3): 1304-1310
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1304
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1304
Antibody | Target antigen | Positive rate | |
Crohn’s disease | Ulcerative colitis | ||
Auto-antibody | |||
pANCA | Nuclear histone 1 of polymorphonuclear leukocytes | 10%-15% | 60%-70% |
Anti-pancreas antibody | A trypsin-sensitive protein in pancreatic juice | 20%-40% | About 10% |
Microbial antibody | |||
ASCA | Mannan in the cell wall of bakers’ yeast | 60%-70% | 10%-15% |
ACCA | Chitobioside in the cell wall of yeasts and bacteria | 20%-40% | About 10% |
ALCA | Laminaribioside in the cell wall of yeasts, fungi, wheat and algae | 20%-40% | About 10% |
AMCA | Mannobioside in the cell wall of microorganisms | - | - |
Anti-OmpC antibody | Outer-membrane protein OmpC of Escherichia coli | 55% | 5%-10% |
Anit-Cbir1 antibody | Flagellin, a component of the flagella of indigenous bacteria in colitis mice | 55% | 10% |
Anti-I2 antibody | I2 component of Pseudomonas fluorescens in mononuclear cells in the intestinal mucosa in Crohn’s disease | 55% | 10% |
- Citation: Mitsuyama K, Niwa M, Takedatsu H, Yamasaki H, Kuwaki K, Yoshioka S, Yamauchi R, Fukunaga S, Torimura T. Antibody markers in the diagnosis of inflammatory bowel disease. World J Gastroenterol 2016; 22(3): 1304-1310
- URL: https://www.wjgnet.com/1007-9327/full/v22/i3/1304.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i3.1304